Sorrento Therapeutics, Inc. Stock
Stocks
SRNE
US83587F2020
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
OTC Markets
04/09/2026
|
5-day change | 1st Jan Change | ||
| 0.000600 USD | 0.00% |
|
+20.00% | -76.92% |
| 03-17 | Semnur Pharmaceuticals, Inc. Announces CEO Changes, Effective March 13, 2026 | CI |
| 03-17 | Semnur Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 67.15M 57.75M 54.31M 49.58M 92.73M 6.35B 93.03M 644M 249M 3.25B 252M 247M 10.36B | P/E 2021 |
-3.2x | P/E 2022 | -0.65x |
|---|---|---|---|---|---|
| Enterprise Value | 152M 130M 123M 112M 209M 14.34B 210M 1.45B 562M 7.35B 570M 557M 23.4B | EV / Sales 2021 |
29.1x | EV / Sales 2022 | 7.89x |
| Free-Float |
98.65% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 week | +20.00% | ||
| Current month | +20.00% | ||
| 1 month | +20.00% | ||
| 3 months | +20.00% | ||
| 6 months | -87.50% | ||
| Current year | -76.92% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.07 |
| 3 years | 0 | | 0.25 |
| 5 years | 0 | | 8.42 |
| 10 years | 0 | | 19.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 61 | 01/04/2011 |
Scott Schaus
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2022 |
John Waldheim
LAW | General Counsel | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Henry Ji
CHM | Chairman | 61 | 01/08/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +20.00% | -83.78% | -99.61% | 326K | |
| -0.38% | -2.64% | +42.69% | +99.03% | 67.98B | |
| -2.71% | -0.71% | +34.08% | +81.43% | 64.94B | |
| -0.31% | +6.54% | -12.96% | +377.83% | 27.58B | |
| +0.86% | +1.65% | -7.74% | -13.58% | 26.06B | |
| -1.42% | -4.28% | +31.24% | +13.27% | 25.74B | |
| -1.11% | +0.90% | +23.12% | -18.50% | 20.09B | |
| +1.15% | -14.24% | +219.82% | +381.14% | 17.16B | |
| +0.20% | -4.68% | -6.41% | +560.92% | 14.92B | |
| -0.20% | +8.37% | +55.78% | +165.57% | 14.62B | |
| Average | -0.39% | +2.94% | +29.58% | +154.75% | 27.91B | |
| Weighted average by Cap. | -0.81% | +0.59% | +36.97% | +141.12% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 52.9M 45.5M 42.79M 39.06M 73.06M 5B 73.29M 507M 196M 2.56B 199M 194M 8.16B | 62.84M 54.04M 50.83M 46.4M 86.78M 5.94B 87.06M 603M 233M 3.04B 236M 231M 9.69B |
| Net income | -428M -368M -346M -316M -591M -40.51B -593M -4.11B -1.59B -20.74B -1.61B -1.57B -66.08B | -573M -493M -463M -423M -791M -54.18B -794M -5.49B -2.12B -27.74B -2.15B -2.1B -88.37B |
| Net Debt | 111M 95.2M 89.54M 81.73M 153M 10.47B 153M 1.06B 410M 5.36B 416M 407M 17.08B | 84.53M 72.69M 68.37M 62.41M 117M 7.99B 117M 811M 313M 4.09B 317M 310M 13.04B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | $0.000600 | 0.00% | 26,035 |
| 03/09/26 | $0.000600 | 0.00% | 91,492 |
| 02/09/26 | $0.000600 | 0.00% | 192,863 |
| 01/09/26 | $0.000600 | +20.00% | 88,266 |
| 31/08/26 | $0.000500 | 0.00% | 26,838 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SRNE Stock
Select your edition
All financial news and data tailored to specific country editions
